Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03397394
Title Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma (ATLAS)
Acronym ATLAS
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Clovis Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | DEU


No variant requirements are available.